Dr. Stefan D. Ursu, MD, PhD

Dr. Ursu practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Ursu's NPI, 1629201561, was assigned on August 26, 2009. Dr. Ursu graduated from University of Medicine and Pharmacy ‘Gr T Popa” Iasi in 1995. Dr. Ursu holds California license A124650.

Dr. Ursu's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Ursu's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Ursu is also affiliated with Riverside University Health System - Medical Center. The medical group on file is High Desert Psychological Services. Dmand AI also links Dr. Ursu to 1 more hospital, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ursu practices, 4 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Ursu's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Ursu is board certified in addiction medicine by the American Board of Preventive Medicine. Dmand AI has Dr. Ursu's licenses on file in 2 states: California and Texas.

Dmand AI lists dementia and psychoses among the conditions Dr. Ursu treats.

CMS data shows 292 Medicare services from Dr. Ursu across 2 procedure codes in 2024, for 66 Medicare patients. Medicare paid $15,584 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Ursu in 2024. The largest group is under 65, with 52 patients. 75% of them have schizophrenia and other psychoses, and 74% have tobacco use. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ursu's median patient age at 53, with 33% women.

In 2024, Dr. Ursu wrote 60 Medicare Part D claims for 16 patients. 97% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $350 in total drug cost. In 2020, CMS named 11 claims across 1 drug.

Dr. Ursu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Ursu, published from 2008 to 2021. 2008 was the busiest year, with 4. The most frequent topics are Magnetic Resonance Imaging, Brain Mapping and Prefrontal Cortex. Dr. Ursu has published most often in Am J Psychiatry. Dr. Ursu's most frequent co-authors are Jong H. Yoon, MD, Michael Joseph Minzenberg, MD and Manish K. Jha, MBBS.

Dmand AI links Dr. Ursu to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Depressive Disorder, Treatment-Resistant, Obsessive-Compulsive Disorder and Anxiety Disorders.

CMS Open Payments shows 3 general payments to Dr. Ursu from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. ITI, Inc. paid the most, $33.

Dr. Ursu graduated from University of Medicine and Pharmacy ‘Gr T Popa” Iasi in 1995.

Dr. Ursu is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Elevance and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.